These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4602984)

  • 1. [Preliminary clinical studies on the antiparkinson effects of 17-monochloroacetylajmaline].
    Errichiello G; Maglione S
    Minerva Med; 1974 May; 65(41):2357-9. PubMed ID: 4602984
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of a dihydromorphanthridine derivative in Parkinson's patients treated with L-dopa. A preliminary report.
    Wycis HT
    Confin Neurol; 1972; 34(2):130-5. PubMed ID: 4666056
    [No Abstract]   [Full Text] [Related]  

  • 3. [Dopamine agonist is effective in Parkinson disease not only against tremor. Depression is also improved].
    MMW Fortschr Med; 2002 May; Suppl 2():88. PubMed ID: 12070869
    [No Abstract]   [Full Text] [Related]  

  • 4. Zotepine reversibly induces akinesia and rigidity in Parkinson's disease patients with resting tremor or drug-induced psychosis.
    Arnold G; Trenkwalder C; Schwarz J; Oertel WH
    Mov Disord; 1994 Mar; 9(2):238-40. PubMed ID: 7910949
    [No Abstract]   [Full Text] [Related]  

  • 5. Piribedil in Parkinsonism.
    Cane DB
    Adv Neurol; 1974; 5():325. PubMed ID: 4613159
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase II multiclinic study of elantrine in parkinsonism.
    Blonsky ER; Ericsson AD; McKinney AS; Rix A; Wang RI; Rimm AA
    Clin Pharmacol Ther; 1974 Jan; 15(1):46-50. PubMed ID: 4587106
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effectiveness and tolerance of piribedil as adjunct therapy to levodopa in patients with Parkinson's disease: a nine month follow up].
    Salazar Tortolero G; Wix Ramos R; Salazar Aladrén P; Jiménez León JC
    Rev Neurol; 2004 Apr 16-30; 38(8):715-9. PubMed ID: 15122540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superior clinical efficacy of Sinement CR 50/200 versus Sinemet 25/100 in patients with fluctuating Parkinson's disease. An open and a double-blind, double-dummy, multicenter treatment evaluation. Dutch Sinement CR Study Group.
    Wolters EC; Horstink MW; Roos RA; Jansen EN
    Adv Neurol; 1993; 60():648-52. PubMed ID: 8420204
    [No Abstract]   [Full Text] [Related]  

  • 9. Identifying poor symptom control in Parkinson's disease.
    Scott L
    Nurs Times; 2006 Mar 21-27; 102(12):30-2. PubMed ID: 16594560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Levodopa as a single treatment of Parkinsonism. Long-term control of 24 cases with discrimination analysis].
    Borromei A; Manzini A
    Minerva Med; 1974 Nov; 65(79):4160-70. PubMed ID: 4610450
    [No Abstract]   [Full Text] [Related]  

  • 11. [Preliminary clinical trial of tetrahydropapaveroline in Parkinson's disease].
    Dordain G; Goujet MA; Simon P
    Therapie; 1974; 29(3):421-34. PubMed ID: 4612860
    [No Abstract]   [Full Text] [Related]  

  • 12. Neuroleptic-induced parkinsonism and Parkinson's disease: differential diagnosis and treatment.
    Hausner RS
    J Clin Psychiatry; 1983 Jan; 44(1):13-6. PubMed ID: 6130081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drugs for Parkinson's Disease.
    Treat Guidel Med Lett; 2004 Jun; 2(22):41-6. PubMed ID: 15529113
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuroprotective agents in Parkinson's disease: clinical evidence and caveats.
    Hälbig TD; Tse W; Olanow CW
    Neurol Clin; 2004 Oct; 22(3 Suppl):S1-S17. PubMed ID: 15501359
    [No Abstract]   [Full Text] [Related]  

  • 15. Tremorlytic activity of budipine: a quantitative study with long-term tremor recordings.
    Spieker S; Löschmann P; Jentgens C; Boose A; Klockgether T; Dichgans J
    Clin Neuropharmacol; 1995 Jun; 18(3):266-72. PubMed ID: 8635185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experience in treating vascular parkinsonism with metamysil].
    Kamenetskiĭ VK
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(3):365-70. PubMed ID: 645311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Parkinson disease].
    Moore AP; Clarke CE
    Praxis (Bern 1994); 2001 Jun; 90(23):1041-6. PubMed ID: 11447724
    [No Abstract]   [Full Text] [Related]  

  • 18. [Kr 339 in the treatment of parkinsonian tremor].
    Iivanainen M
    Duodecim; 1974; 90(8):590-6. PubMed ID: 4605767
    [No Abstract]   [Full Text] [Related]  

  • 19. [Abnormal diurnal somnolence, "sleep attacks" and antiparkinson drugs].
    Rascol O; Ferreira J; Montastruc JL
    Rev Neurol (Paris); 2001 Oct; 157(10):1313-23. PubMed ID: 11885528
    [No Abstract]   [Full Text] [Related]  

  • 20. [Motor symptoms in Parkinson disease].
    Larsen JP; Beiske AG; Bekkelund SI; Dietrichs E; Tysnes OB; Vilming ST; Aasly JO
    Tidsskr Nor Laegeforen; 2008 Sep; 128(18):2068-71. PubMed ID: 18846123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.